ANTX · AN2 Therapeutics, Inc.
$5.84
+0.05 (+0.86%)
At close · Aug 21
Market Cap
$218.49M
Shares
37.74M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2026-04-09 | — | $80,000,000 | — | — | 8-K , filed 2026-04-09 |
Key facts
CIK
1880438
CUSIP
037326105
13F (30d)
66 filings
66 filers
Visit website
Investor relations